Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: May 24, 2011

Premium

Affymetrix has launched its Axiom myDesign Targeted Genotyping Arrays to enable researchers to study mutations in disease pathways and characterize gene-gene interactions.

Customers can now design arrays to genotype between 1,500 and 2.6 million markers per sample, allowing them to move from genome-wide scans to specific disease analyses with different experimental approaches on the same platform, according to the firm. Users can create their own arrays using Affy's Axiom Design Center online tool.

In addition to Axiom myDesign TG Arrays, Affy also released a new version of its Axiom Genomic Database. The database now contains 11 million variants, the firm said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.